Pathstone Holdings
ARKG icon

Pathstone Holdings’s ARK Genomic Revolution ETF ARKG Stock Holding History

Pathstone Holdings’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,686
Closed -$205K – 2251
2024
Q4 		$205K Sell
8,686
-390
-4% -$9.6K ﹤0.01% 2160
2024
Q3 		$232K Sell
9,076
-350
-4% -$8.91K ﹤0.01% 2099
2024
Q2 		$221K Sell
9,426
-2,140
-19% -$54K ﹤0.01% 2101
2024
Q1 		$333K Sell
11,566
-1,575
-12% -$47.4K ﹤0.01% 1884
2023
Q4 		$431K Buy
+13,141
New +$357K ﹤0.01% 1602

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Pathstone Holdings's ARKG Position: Q1 2025 in Review

Pathstone Holdings sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 8,686 shares — an estimated $205K sold.

Pathstone Holdings first reported a position in ARKG in Q4 2023 and held it in 5 quarters. The position peaked at $431K in Q4 2023. 214 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.

  • Pathstone Holdings reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
  • Pathstone Holdings sold 8,686 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $205K.
  • Pathstone Holdings first reported a position in ARK Genomic Revolution ETF in Q4 2023 and held it in 5 quarters.
  • Pathstone Holdings's ARK Genomic Revolution ETF position peaked at $431K in Q4 2023.
  • 214 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.

Based on Pathstone Holdings's 13F filing for Q1 2025, filed 15 May 2025.